body as host test iv. – Flashcards
Unlock all answers in this set
Unlock answersvirulence factors |
ways to colonize and breach host surfaces: -loss of barrier function -adhesion molecules -fimbrae, pili -motility and chemotaxis -proteases -surface binding proteins -bacterial capsules -toxic proteins -variability of surface antigens |
other virulence factors (2) |
- evasion and resistance to antibacterial peptides -iron acquisition compounds |
mechanisms of infectious diseases |
- acquisition of disease -asymptomatic phase -prodromal phase -symptomatic phase -healing convalescence |
determinants of disease |
-Nature of disease: tissue target, entry site, accessibility of virus to target tissue; tissue tropism; permissiveness of viral replication ; viral strain -severity of disease -cytopathicity -health status of patient -virus innoculum
|
cytopathicity: 3 potential outcomes of a viral infection |
1-failed infection--no infection 2-lytic infection--cell death 3-persistent infection--chronic or latent or immortalizing |
herpes virus |
-herpes viridae family (HHV) -herpes simplex virus (HSV 1&2) -varicella zoster virus (VZV)
-epstein barr virus (EBV) -cytomegalovirus (CMV) -HHV 6,7,8 (exanthems) |
herpes virus characteristics
|
-ubitquitous, highly infective, small, five sides figure -ds DNA virus -DNA envelope has 4basic components -classified by virulence in cell structure -viral envelope proteins bind to host cell plasma membrane receptors, enter the cytolasma via endocytosis, virons uncoat, and viral DNA enters host's nucleus -replication will cause mental swelling |
basic characteristics of viruses |
-lack their own metabolism! -can replicate in both pro/eukaryotic cells -contain 2 genomes -coding for structural proteins -non-coding proteins (enzymes such as RNAase and DNAase, and immune signaling proteins) |
how viruses work basically |
attachment penetration uncoating of viral nucleic acid transport of viron synthesis of mRNA replication of viral DNA assembly dispersion of viron out of cell (egress) |
recurrent herpes simplex infections (7 "phases") ; |
-reactivated virus -prodromal symptoms -minimal systemic symptoms -small group of vesicles (new lesions for 1-2 days) -viral shedding(3-5 days) -crusting of vesicles -healing (9-10 days) |
how a virus may get reactivated ; |
-virus hangs out in neural ganglion -during periods of stress or compromised immune system the virus travels down teh axons like a slinky -LAT (latency associated transcriptase) keeps virus dormant--when this gene turns off you get prodromal symptoms which are mostly neural (tingly lips, etc.)
|
primary course of HSV infection |
-incubation of virus for about 5 days ~day "0" pt experiences systemic and local symptoms -systemic--> tender lymph nodes -local->pain/itching/dysuria/malaise/fever/headache ~day 2-5 you see more systemic symptoms -vesicle, wet ulcer, crusting -shedding virus for ten days or so! ~day 15 you begin healing |
recurrent course of HSV infection |
-prodromal symptoms for 1-2 days before day "0" -day "0" get lesions & local symptoms; shedding virus ~day 10, start to heal |
treatment for HSV |
-mostly pallative -hydration -antipyretics -prophylactic tx with acyclovir sometimes -affects immediate early protein gene transcription and/or early protein phase gene transcription *thus inhibits DNA elongation/synthesis |
varicella zoster virus |
-varicella-->chicken pox in kids -longer incubation period (14-17); prodromal rare -lesions develop over 3 days -itchy rash persists for about 1-6 days -crusting and shedding for about 7 days -fever 101-105 degreese -no live attentuated oka vaccine -zoster-->virus reactivated to cause shingles |
shingles |
-prodrome symptoms common for 4-5 days -vesicles develop withint 12-24 hrs and rash persists for 1-7 days -rash forms "belt" or follows CN V1,V2,V3 on face -pustules dry and crust and fall off |
Epstein Barr Virus |
-causes mononucleosis -tx: supportive |
cytomegalovirus |
-opportunistic pathogen activated by immunosuppression |
viral exanthems |
-hand-foot-mouth disease -highly contagious spread by oral fecal route -herpangia (coxsackie virus) -vesicles on soft palate -measles (rubeola) -vaccine -german measles (rubella) -vaccine -fifth disease (parvovirus B19) -"slapped cheeks" -respiratory |
hepatitis |
-inflammation of the liver -toxic -infectious Types A, B, C, D, E |
Hepatitis A |
-infectious -picornavirus -capsid RNA -oral- fecal route |
Hepatitis B |
-serum -hepadnavirus -enveloped DNA -sexual contact |
Type C |
-NonA/NonB -flavivrus -enveloped RNA -sexual contact |
Type D |
-Delta agent -viroid like -enveloped circular RNA -sexual contact |
type E |
-enteric -calicovirus -capsid RNA -oral fecal route |
serum components and indications |
-IgM anti HAV or IgM antiHBc indicate recent or active hepatitis infection -Anti HAV; AntiHbs; Antidelta indicate a past ifnection with hepatitis |
Hep B structure |
-enveloped virion -very stable and resistant to low pH and temperature extremes -easy to transmit -envelope consists of Hep B surface antigens |
Hep B replication |
-virus binds to hepatocyte -enters cell endocytotically -carried to nucleus -uncoats -replicates -goes into membrane vacuole and makes nucleid capsid -excess capsid particles are released when virus exocytoses |
manifestations of Hep B (3) |
-Acute -Chronic -Fulminant |
acute hepatitis B |
-90% of cases -cell mediated immune response shuts down virus and yields resolution |
acute hep B manifestations |
-subclinical, mild, or severe symptoms -severe classified as having jaundice for 4-5 wks -incubation period of 4-26 wks -preicteric phase-prodromal symptoms -icteric phase-jaundice and dark urine results from build up of bilirubin which liver can't break down
|
acute Hep B serotology |
-over period of months -damage to liver causes spike in liver enzymes -at beginning you see HBsAg so you know virus is replicating -towards end you will see anti-HBsAg IgG and yhou know virus is resolved -between those two stages you have the antigen Hep B window where neither are present in serum bc they are binding each other up. |
chronic Hepatitis B |
-9% of cases -cell mediated immune system doesn't clear virus, but does slow down virus development over span of 6 months + -half of these cases resolve -half of these cases are chronic and active and may cause ultimate damage (cirrhosis and carcinoma) |
chronic Hepatitis B manifestations |
-in chronic persistant hepatitis, one is asymptomatic, but still sheds the virus -in chronic active hepatitis, there can be development of carcinoma, cirrhosis, or liver failure but symptoms prior to this point are more mild than acute |
chronic hepatitis B serology |
-over span of years -redundancy in liver may cause enzyme levels to fall -trace the HbsAg & antiHbsAg to detect infectious status
|
chronic Hepatitis B vaccine |
-inactivated HBsAg from human serum (old) -recombinant DNA vaccine with HBsAg gene inserted into plasmid (current) |
hepatitis A |
-picornavirus -very stable in environment for long periods of time and can be frozen for months |
hepatitis A replication |
-liver cell receptors -classic RNA replication/cytoplasmic replication -uncoats and replicates in the cytoplasm -causes cell to lyse |
hepatitis A transmission |
-usually via oral-fecal route/contaminated food & water -after ingestion, virus survives low pH of stomach and crosses intestinal wall into blood stream causing transient viremia -virus gets dumped into liver and the virus causes cell lysis there -virus is dumped into bile where it still survives and gets dumped back into the intestine -virus is excreted in fecal matter to start process again |
clinical syndromes of Hep A |
-much shorter incubation period than B -abrupt onset of symptoms -children tend to be asymptomatic bc of highly responsive cell mediated immune system] -virus is small and will stay in circulation even when you see presence of antibodies and virus may deposit elsewhere (cell walls and joints) -rash and arthritis are rare though -tx: interupt contamination and give immune serum Ig during incubation phase -this is 80-90% effective |
hepatitis C |
-short or long incubation period (avg is about 6-9 wks) -milder symptoms then Hep A/B -icteric phase seldome develops -still see chronic damage though -10-50% of cases become chronic -chronic case increases risk of recurrence in liver transplant -fulminate decreases risk of infectio nof liver transplant -tx: none; but 10-40% cases respond to interferon and ribivinn tx -diagnosis: eliminate possibility of other two types |
delta agent |
-defective satellite virus -can't replicate unless Hepatitis B is suprainfected or Co-infected in same cell -coinfection increases risk of fulminate hepatitis and slightly increases the risk of cirrhosis and carcinoma -complicates but does not cause hepatitis by itself
|
Hep E |
-enterically transmitted (oral-fecal route) -diagnose by excluding other Hep viruses -similar to HAV clinically -short incubation time -abrupt onset of symptoms -no chronic form -no tx or prevention |
virus characteristics |
-filterable, small agents -non living -require host cell's machinery to replicate -have either RNA or DNA genome, but not both -are naked capsid type or enveloped -must encode any required processes not provided by host cell and package specialized proteins and nuclear binding proteins and enzymes |
naked vs enveloped virus |
Naked DNA/RNA+structural proteins+nuclear binding proteins and enzymes=nucleocapsid nucleocapsid+envelop (membrane and glycoproteins)=envelope |
DNA viruses name and differentiate between ds or ss, and enveloped or naked |
-enveloped: Pox, Herpes, hepadna -Naked: polyoma, papilloma, adeno and parvo (ss) |
viral attachment |
-virus has tissue tropism -attaches to target cell via glycoproteins to bind -immn syst recognizes these glycoproteins when in circulation after cell lyses -we use these glycoproteins to create vaccines -glycoproteins fuse cell membranes to make gigantic cells withe several nuclei |
RNA viruses (15) define if ds or ss; and if + or - stranded |
ds: reo ss+ : picorna, corona, noro, toga, flavi, hepatitis, retro ss - : orthomyxo, paramyxo, rhabdo, filo, borna, bunya, arena,
* negative indicates that it is enveloped |
places where drugs can interact to stop viral infection |
-Antibodies prevent virus from attaching -drugs could stop viral uncoating -drugs could stop viral transcription and replication |
steps in viral replication |
1-recognition and attachment 2-penetration 3-uncoating 4-macromolecule synthesis (mRNA & nonstructural proteins; genome replciation; late mRNA & structural proteins; modification of proteins) 5-assembly 6-budding of enveloped virus OR lysis of non enveloped virus 7-release of virus |
viral protein synthesis and protein replication of ds DNA
|
-DS DNA makes mRNA and proteins via host machinery |
viral protein synthesis and genome replication of ss DNA |
-make complement strand of DNA -make mRNA -make proteins |
viral protein synthesis and genome replication of positive stranded RNA |
-positive stranded RNA is like the mRNA that binds to ribosomes and makes one polyprotein that is then cleaved -the mRNA makes a template of - RNA to create +mRNA progenies |
viral proteins synthesis and genome replication of - stranded RNA |
-RNA is transcribed into mRNA segments and then proteins are made -RNA is also made into a full length +RNA template to make (-) RNA progenies by RNA polymerase |
viral protein synthesis and genome replication of ds RNA |
-acts like (-) stranded RNA -transcribed to make mRNA segments by RNA polymerase in capsid |
viral protein synthesis and genome replication of retrovirus |
- (+) stranded RNA are converted to complementary DNA by reverse transcriptase carried in a virion |
-immediate early and early phase viral proteins are _____1________ for ______2__________ ____________ are produced. an example is ________3_______ carried with virus |
1-necessary 2-DNA synthesis 3-RNA dependent RNA polymerase |
late genes most encode viral ____________ proteins which requires viral DNA synthesis |
-structural |
papilloma virus characteristics and pathology |
-small, nonenveloped icosahedral virus; ds DNA -encode proteins that promote cell growth -may oncogenetically transfer a cell that is non permissive -causes warts and human cervical carcinoma -infects squamous epithelium & mucosal membrane -virus accesses the basal cell layer through breaks in skin causing basal cell to grow and cell # increases -this leads to thickenings and causes the wart/papilloma |
HPV proteins |
-E1 protein binds to DNA @ origin to promote replication -E6 and E7 are immortalizing genes -E6 binds w p53 protein and targets it for degradation -E7 deactivates p105RB; thus NO BRAKES on cell growth |
polyomaviridae |
-like HPV -T antigen analogous to E6&E7 -JC virus establishes kidney infection -BK virus establishes latent kidney infection -respiratory tract-->viremia-->kidney inf.-->viremia--> -immunocompetent patients experience latency -reactivation of BK virus causes hemmorrhagic cystitis in urinary tract -reactivation of JC virus is in the CNS |
adenovirus structure characteristics and replication |
-capsid made of capsidmeres -spikes protrude as ligand receptors and are made of glycoproteins -nonenveloped icosadeltahedron -potential to become oncogenic -replication: -requirements for transcription of early proteins: E1 gene transcription; process of primary transcript; translate immediate early E1A transactivator protein (controll/growth supressor) -end result is host cell death |